CONCLUSION : Based on our meta-analysis , the CYP3A4 * 1B genetic polymorphism affects tacrolimus dose requirements and tacrolimus trough concentration/weight-adjusted tacrolimus daily dose ratio within the first year post- transplantation in adult renal transplant recipients , especially in European recipients ( mostly Caucasian ) .